G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Market Cap	2.93B
Revenue (ttm)	294.26M
Net Income (ttm)	134.60M
Shares Out	59.00M
EPS (ttm)	2.11
PE Ratio	23.56
Forward PE	n/a
Dividend	0.70 (1.39%)
Ex-Dividend Date	Jul 29, 2025

Volume	18,204
Average Volume	26,793
Open	50.20
Previous Close	50.40
Day's Range	49.70 - 50.30
52-Week Range	41.67 - 57.13
Beta	-0.90
RSI	54.58
Earnings Date	Aug 7, 2025

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products. It offers Hepanamin capsules; botoniocal healthcare products; botanical anti-aging cosmetics, which includes facial cleansing essence, botonic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; and adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 39
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4911

Financial Performance

In 2024, G&E Herbal Biotechnology's revenue was 249.03 million, an increase of 37.25% compared to the previous year's 181.44 million. Earnings were 102.06 million, an increase of 40.97%.